{
  "compound": "Nabiximols (THC:CBD 1:1)",
  "condition": "MULTIPLE_SCLEROSIS",
  "effect_size": "Medium-large (Cohen's d = 0.71)",
  "study_type": "RCT",
  "source": "NORML:MS_RCT_005",
  "participants": "135 MS patients with overactive bladder",
  "year": 2010,
  "notes": "Cannabinoids for Bladder Dysfunction in Multiple Sclerosis",
  "confidence": "medium",
  "abstract": "Nabiximols: 38% reduction in episodes vs Placebo: 18% reduction (p=0.001)"
}